BioSpace1 小时
RAPT Crashes After Axing Atopic Dermatitis, Asthma Hopeful, Cites Liver Injury
In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.
Indy 100 on MSN1 小时
FDA issue order against common ingredient found in cold and flu medicine
The US Food and Drug Administration (FDA) has proposed an order to ban a popular ingredient in cold and flu medicines as it is seemingly not as effective as other methods. Oral phenylephrine is often ...
Atlanta Journal-Constitution2 小时
FDA proposes pulling decongestants from shelves over one ingredient
Just as cold and flu season arrives, the Food and Drug Administration proposes pulling many decongestants from store shelves. The reason? An administration review found oral phenylephrine — a common ...
Wisconsin’s high court to hear oral arguments on whether an 1849 abortion ban remains valid
The Wisconsin Supreme Court will hear oral arguments on whether a law that legislators adopted more than a decade before the ...
Yahoo8 小时
FDA to Finally Ban Controversial Ingredient in Popular Decongestants
These popular brand names appear on oral decongestants that are staples of the cold and flu aisle in American drug stores, ...
FDA wants to pull decongestant found in many cold, allergy medicines
The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...